Advertisement
Screener

Decoy Therapeutics Inc. (DCOY) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

2.8 / 5 stars · 68/120 Roast Me

Decoy Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

Decoy Therapeutics Inc. (DCOY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-12

  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 4.00 shares, a 99.82% decline from fiscal 2023.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 2.23K shares, a 67.13% decline from fiscal 2022.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 6.78K shares, a 276.44% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 10 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed
2026-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
0.00 shares
10-Q · filed 2026-08-12
0.00 shares
derived: sum of 3 quarters · filed 2026-08-12
0.00 shares
derived: sum of 4 quarters · filed 2026-08-12
2026-03-310.00 shares
10-Q · filed 2026-05-08
0.00 shares
derived: sum of 2 quarters · filed 2026-05-08
0.00 shares
derived: sum of 3 quarters · filed 2026-05-08
0.00 shares
derived: sum of 4 quarters · filed 2026-08-12
2025-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
0.00 shares
derived: sum of 2 quarters · filed 2026-03-31
0.00 shares
derived: sum of 3 quarters · filed 2026-08-12
0.00 shares
10-K · filed 2026-03-31
2025-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
0.00 shares
derived: sum of 2 quarters · filed 2026-08-12
0.00 shares
10-Q · filed 2025-11-14
-45.00 shares
derived: sum of 4 quarters · filed 2026-08-12
2025-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
0.00 shares
10-Q · filed 2026-08-12
-45.00 shares
derived: sum of 3 quarters · filed 2026-08-12
-731.00 shares
derived: sum of 4 quarters · filed 2026-08-12
2025-03-310.00 shares
10-Q · filed 2026-05-08
-45.00 shares
derived: sum of 2 quarters · filed 2026-05-08
-731.00 shares
derived: sum of 3 quarters · filed 2026-05-08
-731.00 shares
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-45.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-731.00 shares
derived: sum of 2 quarters · filed 2026-03-31
-731.00 shares
derived: sum of 3 quarters · filed 2026-03-31
4.00 shares
10-K · filed 2026-03-31
735.00 shares
10-K · filed 2025-03-21
2024-09-30-686.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-686.00 shares
derived: sum of 2 quarters · filed 2025-11-14
49.00 shares
10-Q · filed 2025-11-14
735.00 shares
10-Q · filed 2024-11-14
2.28K shares
derived: sum of 4 quarters · filed 2025-11-14
2024-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
735.00 shares
10-Q · filed 2025-08-12
2.96K shares
derived: sum of 3 quarters · filed 2025-08-12
2.96K shares
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31735.00 shares
10-Q · filed 2025-05-14
5.88K shares
10-Q · filed 2024-05-13
2.96K shares
derived: sum of 2 quarters · filed 2025-05-14
2.96K shares
derived: sum of 3 quarters · filed 2025-05-14
2.96K shares
derived: sum of 4 quarters · filed 2025-05-14
2023-12-312.23K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
2.23K shares
derived: sum of 2 quarters · filed 2025-03-21
2.23K shares
derived: sum of 3 quarters · filed 2025-03-21
2.23K shares
10-K · filed 2025-03-21
17.82K shares
10-K · filed 2024-03-22
2023-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
0.00 shares
derived: sum of 2 quarters · filed 2024-11-14
0.00 shares
10-Q · filed 2024-11-14
1.76K shares
derived: sum of 4 quarters · filed 2024-11-14
2023-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
0.00 shares
10-Q · filed 2024-08-09
1.76K shares
derived: sum of 3 quarters · filed 2024-08-09
6.30K shares
derived: sum of 4 quarters · filed 2024-08-09
2023-03-310.00 shares
10-Q · filed 2024-05-13
1.76K shares
derived: sum of 2 quarters · filed 2024-05-13
6.30K shares
derived: sum of 3 quarters · filed 2024-05-13
6.78K shares
derived: sum of 4 quarters · filed 2024-05-13
2022-12-311.76K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
6.30K shares
derived: sum of 2 quarters · filed 2024-03-22
6.78K shares
derived: sum of 3 quarters · filed 2024-03-22
6.78K shares
10-K · filed 2024-03-22
2022-09-304.54K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
5.01K shares
derived: sum of 2 quarters · filed 2023-11-09
5.01K shares
10-Q · filed 2023-11-09
5.01K shares
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30480.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
480.00 shares
10-Q · filed 2023-08-10
12.00K shares
10-Q · filed 2022-08-05
480.00 shares
derived: sum of 3 quarters · filed 2023-08-10
-42.72K shares
derived: sum of 4 quarters · filed 2023-08-10
2022-03-310.00 shares
10-Q · filed 2023-05-11
0.00 shares
derived: sum of 2 quarters · filed 2023-05-11
-43.20K shares
derived: sum of 3 quarters · filed 2023-05-11
1.80K shares
derived: sum of 4 quarters · filed 2023-05-11
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
-43.20K shares
derived: sum of 2 quarters · filed 2023-03-27
1.80K shares
derived: sum of 3 quarters · filed 2023-03-27
1.80K shares
10-K · filed 2023-03-27
45.00K shares
10-K · filed 2022-03-25
2021-09-30-43.20K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
1.80K shares
derived: sum of 2 quarters · filed 2022-11-10
1.80K shares
10-Q · filed 2022-11-10
45.00K shares
10-Q · filed 2021-11-04
1.80K shares
derived: sum of 4 quarters · filed 2022-11-10
2021-06-3045.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
45.00K shares
10-Q · filed 2022-08-05
45.00K shares
derived: sum of 3 quarters · filed 2022-08-05
55.61K shares
derived: sum of 4 quarters · filed 2022-08-05
2021-03-310.00 shares
10-Q · filed 2022-05-12
0.00 shares
derived: sum of 2 quarters · filed 2022-05-12
10.61K shares
derived: sum of 3 quarters · filed 2022-05-12
26.61K shares
derived: sum of 4 quarters · filed 2022-05-12
2020-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25
10.61K shares
derived: sum of 2 quarters · filed 2022-03-25
26.61K shares
derived: sum of 3 quarters · filed 2022-03-25
36.61K shares
10-K · filed 2022-03-25
2020-09-3010.61K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
26.61K shares
derived: sum of 2 quarters · filed 2021-11-04
36.61K shares
10-Q · filed 2021-11-04
36.61K shares
derived: sum of 4 quarters · filed 2021-11-04
2020-06-3016.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
26.00K shares
10-Q · filed 2021-08-05
26.00K shares
derived: sum of 3 quarters · filed 2021-08-05
26.00K shares
derived: sum of 4 quarters · filed 2021-08-05
2020-03-3110.00K shares
10-Q · filed 2021-05-12
10.00K shares
derived: sum of 2 quarters · filed 2021-05-12
10.00K shares
derived: sum of 3 quarters · filed 2021-05-12
10.00K shares
derived: sum of 4 quarters · filed 2021-05-12
2019-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
0.00 shares
derived: sum of 2 quarters · filed 2021-03-18
0.00 shares
derived: sum of 3 quarters · filed 2021-03-18
0.00 shares
10-K · filed 2021-03-18
2019-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
0.00 shares
derived: sum of 2 quarters · filed 2019-11-12
0.00 shares
10-Q · filed 2019-11-12
144.84K shares
derived: sum of 4 quarters · filed 2019-11-12
2019-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-17
0.00 shares
10-Q · filed 2019-07-17
144.84K shares
derived: sum of 3 quarters · filed 2019-07-17
238.26K shares
derived: sum of 4 quarters · filed 2019-07-17
2019-03-310.00 shares
10-Q · filed 2019-05-01
144.84K shares
derived: sum of 2 quarters · filed 2019-05-01
238.26K shares
derived: sum of 3 quarters · filed 2019-05-01
643.19K shares
derived: sum of 4 quarters · filed 2019-05-01
2018-12-31144.84K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
238.26K shares
derived: sum of 2 quarters · filed 2019-03-06
643.19K shares
derived: sum of 3 quarters · filed 2019-03-06
859.54K shares
10-K · filed 2019-03-06
2018-09-3093.42K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
498.35K shares
derived: sum of 2 quarters · filed 2018-11-05
714.70K shares
10-Q · filed 2018-11-05
661.74K shares
derived: sum of 4 quarters · filed 2018-11-05
2018-06-30404.93K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
621.28K shares
10-Q · filed 2018-08-01
568.32K shares
derived: sum of 3 quarters · filed 2018-08-01
760.59K shares
derived: sum of 4 quarters · filed 2018-08-01
2018-03-31216.35K shares
10-Q · filed 2018-05-02
163.39K shares
derived: sum of 2 quarters · filed 2018-05-02
355.65K shares
derived: sum of 3 quarters · filed 2018-05-02
563.31K shares
derived: sum of 4 quarters · filed 2018-05-02
2017-12-31-52.96K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07
139.31K shares
derived: sum of 2 quarters · filed 2018-03-07
346.96K shares
derived: sum of 3 quarters · filed 2018-03-07
418.64K shares
10-K · filed 2018-03-07
2017-09-30192.26K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
399.92K shares
derived: sum of 2 quarters · filed 2017-11-06
471.60K shares
10-Q · filed 2017-11-06
639.10K shares
derived: sum of 4 quarters · filed 2017-11-06
2017-06-30207.66K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
279.34K shares
10-Q · filed 2017-08-02
446.83K shares
derived: sum of 3 quarters · filed 2017-08-02
609.49K shares
derived: sum of 4 quarters · filed 2017-08-02
2017-03-3171.68K shares
10-Q · filed 2017-05-03
239.18K shares
derived: sum of 2 quarters · filed 2017-05-03
401.83K shares
derived: sum of 3 quarters · filed 2017-05-03
446.07K shares
derived: sum of 4 quarters · filed 2017-05-03
2016-12-31167.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08
330.15K shares
derived: sum of 2 quarters · filed 2017-03-08
374.39K shares
derived: sum of 3 quarters · filed 2017-03-08
423.53K shares
10-K · filed 2017-03-08
2016-09-30162.66K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
206.89K shares
derived: sum of 2 quarters · filed 2016-11-02
256.03K shares
10-Q · filed 2016-11-02
261.03K shares
derived: sum of 4 quarters · filed 2016-11-02
2016-06-3044.24K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
93.38K shares
10-Q · filed 2016-08-03
98.38K shares
derived: sum of 3 quarters · filed 2016-08-03
115.85K shares
derived: sum of 4 quarters · filed 2016-08-03
2016-03-3149.14K shares
10-Q · filed 2016-05-04
54.14K shares
derived: sum of 2 quarters · filed 2016-05-04
71.61K shares
derived: sum of 3 quarters · filed 2016-05-04
75.11K shares
derived: sum of 4 quarters · filed 2016-05-04
2015-12-315.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08
22.48K shares
derived: sum of 2 quarters · filed 2016-03-08
25.98K shares
derived: sum of 3 quarters · filed 2016-03-08
49.33K shares
10-K · filed 2016-03-08
2015-09-3017.48K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
20.98K shares
derived: sum of 2 quarters · filed 2015-11-04
44.33K shares
10-Q · filed 2015-11-04
2015-06-303.50K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
26.85K shares
10-Q · filed 2015-08-05
2015-03-3123.35K shares
10-Q · filed 2015-05-06
2014-12-3179.83K shares
10-K · filed 2015-03-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Silo Pharma, Inc. (SILO)United States$0.003B-1.57